Guben Kechuan granules for COPD recovery after hospital stay
Part of Lungs & breathing clinical trials.
This trial tests a traditional Chinese medicine granule called Guben Kechuan to help people with COPD recover faster after a hospital stay for a flare-up. It may improve your immune system and reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with moderate to very severe COPD (Grade II–IV).
- You are currently in the hospital for a sudden flare-up of your COPD and are about to be discharged.
- You are between 40 and 75 years old.
- You have not taken the study drug (Guben Kechuan Granules) before.
- You do not have other lung diseases like asthma, tuberculosis, or lung cancer.
- You are willing to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a traditional Chinese herbal compound formula for people with COPD. It aims to see if the herbal treatment can help improve lung health when used on top of standard inhaler therapy.
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
This trial tests whether two Chinese herbal medicines, Bailing capsules and Guben Kechuan granules, can help people with stable bronchiectasis. It aims to reduce flare-ups and improve lung function.
This trial tests if a traditional Chinese medicine treatment can help people with a severe worsening of COPD. It is designed for those who have specific Chinese medicine patterns and are willing to try an additional therapy during their hospital stay.
This trial tests a traditional Chinese herbal formula for treating sudden worsening of COPD symptoms (called acute exacerbations). It may help reduce inflammation and improve breathing during a flare-up for hospitalized patients.
This trial tests a Chinese herbal prescription (Bufei Yishen) to see if it can reduce frequent acute flare-ups in people with stable COPD. It may help if you've had multiple exacerbations despite using a triple inhaler for at least 3 months.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.